Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario

G Boriani, N Bonini, A Albini… - Polish Heart …, 2020 - journals.viamedica.pl
Atrial fibrillation (AF) represents the most common arrhythmia and is associated with
increased morbidity and mortality generating high social costs. Due to its high prevalence …

Pharmacological cardioversion of atrial fibrillation: current management and treatment options

G Boriani, I Diemberger, M Biffi, C Martignani, A Branzi - Drugs, 2004 - Springer
Atrial fibrillation (AF) is the most common form of arrhythmia, carrying high social costs. It is
usually first seen by general practitioners or in emergency departments. Despite the …

Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs

RJ Schilling - Heart, 2010 - heart.bmj.com
Atrial fibrillation (AF) is the commonest atrial arrhythmia and represents a large burden on
modern health services. Large multicentre randomised trials have demonstrated that a …

Demographic and clinical characteristics of patients with atrial fibrillation and cardioversion as planned therapeutic options in the International Registry on …

R Dąbrowski, G Opolski, P Włodarczyk… - Kardiologia Polska …, 2014 - journals.viamedica.pl
Background: Cardioversion of atrial fibrillation (AF) and maintenance of sinus rhythm are the
basic strategies of treating AF patients. Precise data regarding the current practice of AF …

Cardioversion of atrial fibrillation (RHYTHM-AF) international registry in Poland

M Kiliszek, G Opolski, P Włodarczyk… - Cardiology …, 2014 - journals.viamedica.pl
Background: A key procedure of the rhythm control strategy in atrial fibrillation (AF) is
cardioversion to normal sinus rhythm. The aim of the present study was to provide a review …

Pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis

IS deSouza, M Tadrous, T Sexton, R Benabbas… - EP …, 2020 - academic.oup.com
Aims We sought to identify the most effective antidysrhythmic drug for pharmacologic
cardioversion of recent-onset atrial fibrillation (AF). Methods and results We searched …

[HTML][HTML] Cardioversion in non-valvular atrial fibrillation

HH Klein, HJ Trappe - Deutsches Ärzteblatt International, 2015 - ncbi.nlm.nih.gov
Background Atrial fibrillation is the most common type of cardiac arrhythmia and is
associated with elevated rates of stroke, heart failure, hospital admission, and death. Its …

Anticoagulation in atrial fibrillation cardioversion: what is crucial to take into account

F Luca, S Giubilato, SA Di Fusco, L Piccioni… - Journal of Clinical …, 2021 - mdpi.com
The therapeutic dilemma between rhythm and rate control in the management of atrial
fibrillation (AF) is still unresolved and electrical or pharmacological cardioversion (CV) …

How to optimize cardioversion of atrial fibrillation

KEJ Airaksinen - Journal of Clinical Medicine, 2022 - mdpi.com
Cardioversion (CV) is an essential component of rhythm control strategy in the treatment of
atrial fibrillation (AF). Timing of CV is an important manageable factor in optimizing the safety …

Pharmacological cardioversion of recent onset atrial fibrillation

IA Khan - European heart journal, 2004 - academic.oup.com
Atrial fibrillation is the most common, clinically relevant arrhythmia with a prevalence of
about 2% in the general population. The symptoms in atrial fibrillation are primarily caused …